Published in J Am Med Dir Assoc on January 08, 2011
Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res (2013) 1.27
The Analytic Information Warehouse (AIW): a platform for analytics using electronic health record data. J Biomed Inform (2013) 1.20
Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One (2013) 1.10
Causes and patterns of readmissions in patients with common comorbidities: retrospective cohort study. BMJ (2013) 1.04
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging (2013) 0.96
Semantic ETL into i2b2 with Eureka! AMIA Jt Summits Transl Sci Proc (2013) 0.92
Institutionalization following incident non-traumatic fractures in community-dwelling men and women. Osteoporos Int (2011) 0.90
Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized older patients. BMC Geriatr (2014) 0.82
Comparing Comorbidity Indices to Predict Post-Acute Rehabilitation Outcomes in Older Adults. Am J Phys Med Rehabil (2016) 0.82
The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level. PLoS One (2016) 0.82
A systematic review protocol for measuring comorbidity in inpatient rehabilitation for non-traumatic brain injury. Syst Rev (2015) 0.77
Apples and Oranges: Four Definitions of Multiple Chronic Conditions and their Relationship to 30-Day Hospital Readmission. J Am Geriatr Soc (2017) 0.75
Comparing the predictive accuracy of frailty, comorbidity, and disability for mortality: a 1-year follow-up in patients hospitalized in geriatric wards. Clin Interv Aging (2017) 0.75
Central Nervous System Medication Burden and Serious Falls in Older Nursing Home Residents. J Am Geriatr Soc (2017) 0.75
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45
Looking forward to a general theory on population aging. J Gerontol A Biol Sci Med Sci (2004) 9.48
NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J (2007) 3.88
Ageing and infection. Lancet Infect Dis (2002) 3.79
Death toll exceeded 70,000 in Europe during the summer of 2003. C R Biol (2007) 2.88
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev (2005) 2.78
Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem (2002) 2.41
NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal (2009) 2.38
NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem (2004) 2.36
Procalcitonin and infection in elderly patients. J Am Geriatr Soc (2005) 2.20
Pneumonia in the very old. Lancet Infect Dis (2004) 2.19
Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol (2009) 2.18
Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol (2012) 2.17
Decreased blood pressure in NOX1-deficient mice. FEBS Lett (2005) 2.10
Older patients in the emergency department: a review. Ann Emerg Med (2010) 2.06
Exploring the impact of climate on human longevity. Exp Gerontol (2012) 2.03
Who will care for the oldest people in our ageing society? BMJ (2007) 2.01
Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol (2009) 2.01
NOX enzymes as novel targets for drug development. Semin Immunopathol (2008) 1.90
Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry (2002) 1.88
Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem (2004) 1.86
Frailty syndrome: a transitional state in a dynamic process. Gerontology (2009) 1.80
Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal (2009) 1.80
A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal (2011) 1.79
Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trial. Arch Intern Med (2010) 1.78
The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell (2006) 1.76
Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res (2009) 1.75
Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke (2004) 1.74
A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. Stem Cells (2009) 1.71
NOX family NADPH oxidases: not just in mammals. Biochimie (2007) 1.68
Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2007) 1.65
Fighting against age discrimination in clinical trials. J Am Geriatr Soc (2010) 1.63
Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care (2010) 1.63
Does dementia predict adverse hospitalization outcomes? A prospective study in aged inpatients. Int J Geriatr Psychiatry (2009) 1.62
Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease. Aging Clin Exp Res (2009) 1.61
Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci (2007) 1.52
Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis. BJU Int (2007) 1.49
Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem Cells (2005) 1.48
Symptom relief in the last week of life: is dementia always a limiting factor? J Am Geriatr Soc (2007) 1.48
Is research really problematic in palliative care? A pilot study. J Pain Symptom Manage (2005) 1.45
Distinction between perceptual and attentional processing in working memory tasks: a study of phase-locked and induced oscillatory brain dynamics. J Cogn Neurosci (2007) 1.45
Relationships between dual-task related changes in stride velocity and stride time variability in healthy older adults. Hum Mov Sci (2006) 1.44
Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain (2007) 1.44
Endocarditis in older people. Age Ageing (2002) 1.40
Stride-to-stride variability while backward counting among healthy young adults. J Neuroeng Rehabil (2005) 1.37
Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol (2008) 1.37
Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol (2011) 1.35
Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J Neurosci (2008) 1.34
Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status. Age Ageing (2007) 1.32
Gait variability among healthy adults: low and high stride-to-stride variability are both a reflection of gait stability. Gerontology (2009) 1.31
Alzheimer disease therapy--moving from amyloid-β to tau. Nat Rev Neurol (2013) 1.31
NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med (2009) 1.30
NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension (2007) 1.29
Aging and infectious diseases in the developing world. Clin Infect Dis (2004) 1.29
Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia. J Immunol (2005) 1.27
Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke (2005) 1.26
NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol (2010) 1.25
Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun (2012) 1.25
Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging (2012) 1.22
Changes in gait while backward counting in demented older adults with frontal lobe dysfunction. Gait Posture (2007) 1.22
Feasibility and reliability of four pain self-assessment scales and correlation with an observational rating scale in hospitalized elderly demented patients. J Gerontol A Biol Sci Med Sci (2005) 1.20
NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans (2008) 1.20
Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol (2014) 1.18
NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie (2007) 1.17
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol (2006) 1.17
Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry (2009) 1.17
Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol (2003) 1.15
A pure population of ectodermal cells derived from human embryonic stem cells. Stem Cells (2007) 1.13
Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2. Cancer Res (2009) 1.12
Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis (2010) 1.10
Pathological substrates of cognitive decline in Alzheimer's disease. Front Neurol Neurosci (2009) 1.10
Gait control: a specific subdomain of executive function? J Neuroeng Rehabil (2012) 1.10
Pain in severe dementia: self-assessment or observational scales? J Am Geriatr Soc (2006) 1.09
Brief report: beyond clinical experience: features of data collection and interpretation that contribute to diagnostic accuracy. J Gen Intern Med (2006) 1.09
Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J Cell Sci (2006) 1.08
NOX5: from basic biology to signaling and disease. Free Radic Biol Med (2011) 1.08
Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing (2009) 1.08
Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc (2008) 1.07
Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX (2010) 1.06
Gait alterations of diabetic patients while walking on different surfaces. Gait Posture (2009) 1.06
New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal (2014) 1.06